Lisa Soyeon Park has held various roles throughout their career. Lisa Soyeon began their career at Biomedlab Co. in 1999, where they served as the Director of Biochip R&D until 2004. From 2004 to 2009, they worked at the Korea Institute of Toxicology as the Director of Business Development & Regulatory Affairs. In 2009, they joined Qion Pte Ltd as the CSO, a role they held until 2015. Since 2015, Lisa has been the CEO of Prestige BioPharma Ltd.
Lisa Soyeon Park completed their PhD in Bioorganic Chemistry/Analytical Chemistry at the University of Missouri-Columbia from 1991 to 1995. Lisa Soyeon then pursued a Postdoc degree in Toxicology/Environmental Health at the Massachusetts Institute of Technology from 1996 to 1999.
Org chart
Sign up to view 2 direct reports
Get started
Teams
This person is not in any teams